...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: Trading
1
Sep 19, 2022 03:22PM
1
Sep 20, 2022 02:03PM
3
Sep 20, 2022 03:01PM
3
Sep 20, 2022 05:13PM
4
Sep 20, 2022 06:22PM
4
Sep 21, 2022 12:02PM
2
Sep 21, 2022 01:26PM
2
Sep 21, 2022 04:29PM
2
Sep 21, 2022 07:27PM
3
Sep 21, 2022 08:34PM
5
Sep 22, 2022 03:16PM
6
Sep 22, 2022 03:27PM

acchhh,,well,,really,,what else would we expect from RVX management,,they couldnt organize a one car funeral. They have no intention to create liquidity for Zenith shareholders,,,and as we head into the 10th year at being at arms length from our shares. !!

 

Share
New Message
Please login to post a reply